YorkTest Laboratories Limited has been acquired by Ingemino Ltd.
YorkTest Laboratories Limited (YorkTest), Europe’s leading food intolerance (delayed food allergy) testing company, has been acquired by Ingemino Ltd., a newly established company formed by successful entrepreneurs Keith Tozzi and Fiona Begley. Financial details will remain confidential.
YorkTest manufactures and markets a number of self-test services of laboratory analyzed diagnostic home health tests direct to consumers, to medical laboratories and to practitioners both in the UK and in over 50 countries around the world. The company’s aim is to empower people with informed, personal insights to enable them to change their diet and improve their health. Combined with increasing media coverage and powerful endorsements from key opinion leaders, including world renowned marathon runner Paula Ratcliffe, YorkTest has seen sustained profitable growth over the past few years. Tom Hardman, YorkTest’s Managing Director, will join the board of Ingemino.
Ingemino Ltd. is a newly formed company that has been established to acquire, develop and grow a series of key businesses in the testing arena. The focus of the business is laboratory-based testing solutions and the key objective is to develop Ingemino into a world-class organization through a combination of complementary acquisitions and aggressive organic growth. The acquisition was supported by Close Brothers Private Equity (CPBE Capital).
Oaklins Cavendish, based in the UK, advised the seller in this transaction.


Talk to the deal team
Lord Leigh of Hurley
Oaklins Cavendish
Related deals
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Learn moreCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Learn moreiwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn more